Gene · 10403
Papers2,370
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,370
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of exosome-related gene features in psoriasis and construction of a diagnostic model via integrated bioinformatics analysis. | Comput Methods Biomech Biomed Engin | 2026 | 39358990 | PubTator, text mining | PubMed |
| Assessing Flooding from Changes in Extreme Rainfall: Using the Design Rainfall Approach in Hydrologic Modeling. | Water (Basel) | 2025 | 42088072 | PubTator, text mining | PubMed |
| Introducing Critical Genes Related to X-ray Radiation in Human Bronchial Epithelial BEAS-2B Cells. | Tanaffos | 2025 | 42027435 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Screenings Reveal the Role of STX1A and CDK1 in Cathepsin G Entering and Killing Colorectal Cancer Cells. | Interdiscip Inf Sci | 2025 | 41929432 | PubTator, text mining | PubMed |
| Mammalian metaphase kinetochores are elastic and require condensin for robust structure and function. | bioRxiv | 2025 | 41497619 | PubTator, text mining | PubMed |
| Ligand Valency and Linker Design Dictate the Efficacy of CI-M6PR-Mediated Targeted Delivery of M6P-siRNA Conjugates. | ACS Omega | 2025 | 41487160 | PubTator, text mining | PubMed |
| Developing the Community Paramedicine Needs Assessment Tool. | Nurs Rep | 2025 | 41441370 | PubTator, text mining | PubMed |
| Multidimensional Datasets Supporting Vulnerability Assessments of Riverine Bridges in Peru. | Sci Data | 2025 | 41390684 | PubTator, text mining | PubMed |
| A Macrophage-Derived 7-Gene Signature Predicts Prognosis and Therapeutic Response in Hepatocellular Carcinoma. | IUBMB Life | 2025 | 41355397 | PubTator, text mining | PubMed |
| TIM-3 Promotes Proliferation of Acute Myeloid Leukemia Blasts. | Biomedicines | 2025 | 41301931 | PubTator, text mining | PubMed |
| Hepatitis E virus screening in solid organ transplant recipients: prevalence and implications for implementation, Spain, 2021 to 2023. | Euro Surveill | 2025 | 41199705 | PubTator, text mining | PubMed |
| Identification of Prognostic Gene Signatures for Survival of Patients With Phaeochromocytoma, Paraganglioma, and Other Tumor Types. | Cancer Diagn Progn | 2025 | 41179328 | PubTator, text mining | PubMed |
| How augmin establishes the angle of the microtubule branch site. | Nat Commun | 2025 | 41173848 | PubTator, text mining | PubMed |
| Kinetochore-centrosome feedback linking CENP-E and Aurora kinases controls chromosome congression. | Nat Commun | 2025 | 41120338 | PubTator, text mining | PubMed |
Tumor microenvironment delineates differential responders to trastuzumab emtansine in HER2-positive metastatic breast cancer patients previously treated with pyrotinib: an exploratory biomarker analysis of a phase II study (NJMU-BC02). | Signal Transduct Target Ther | 2025 | 41016944 | PubTator, text mining | PubMed |
| Ndc80 complex, a conserved coupler for kinetochore-microtubule motility, is a sliding molecular clutch. | Sci Adv | 2025 | 40901966 | PubTator, text mining | PubMed |
| Uncovering novel functions of NUF2 in glioblastoma and MRI-based expression prediction. | Sci Rep | 2025 | 40890233 | PubTator, text mining | PubMed |
| Identification of Proteomic Biomarkers and Therapeutic Targets for Vitiligo Using a Two-Sample Proteome-Wide Mendelian Randomization Approach. | J Cosmet Dermatol | 2025 | 40856249 | PubTator, text mining | PubMed |
| CENcyclopedia: dynamic landscape of kinetochore architecture throughout the cell cycle. | Nat Commun | 2025 | 40825761 | PubTator, text mining | PubMed |
| Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005-2025). | J Cancer Res Clin Oncol | 2025 | 40817296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10403/papers?page=3